Selected publications:
Kelly GL, Stylianou J, Rasaiyaah J, Wei W, Thomas W, Croom-Carter D, Kohler C, Spang R, Woodman C, Kellam P, Rickinson AB, Bell AI. (2013). Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature. J Virol 87:2882-94.
Rowe, M, Fitzsimmons, L, Bell, AI (2014). Epstein-Barr virus and Burkitt lymphoma. Chin J Cancer 12:609-619 doi: 10.5732/cjc.014.10190.
Burns DM, Tierney R, Shannon-Lowe C, Croudace J, Inman C, Abbotts B, Nagra S, Fox CP, Chaganti S, Craddock C, Moss P, Rickinson AB, Rowe M, Bell AI (2015). Memory B cell reconstitution following allogeneic haematopoietic stem cell transplantation is an EBV-associated transformation event. Blood 126:2665-75. Epub 2015 Oct 8. PMID: 26450987 DOI: 10.1182/blood-2015-08-665000
Jayasooriya S, de Silva TI, Njie-Jobe J, Sanyang C, Leese AM, Bell AI, McAulay KA, Yanchun P, Long HM, Dong T, Whittle HC, Rickinson AB, Rowland-Jones, SL, Hislop AD, Flanagan KL (2015). Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children. PLoS Pathog 11: e1004746. eCollection 2015 Mar. PMID: 25816224 DOI: 10.1371/journal.ppat.1004746
Tierney RJ, Nagra J, Rowe M, Bell AI, Rickinson AB (2015). The Epstein-Barr virus BamHI C promoter is not essential for B cell immortalisation in vitro but greatly enhances B cell growth transformation. J Virol 89:2483-93. Epub 2014 Dec 24. PMID: 25540367 DOI: 10.1128/JVI.03300-14
Tierney RJ, Shannon-Lowe C, Fitzsimmons L, Bell AI and Rowe M. Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA. (2015) Virology 474:117-30. Epub 2014 Nov 15. PMID 25463610 DOI 10.1016/j.virol.2014.10.030
Van den Heuvel D, Jansen MA, Bell AI, Rickinson AB, Joddoe VW, van Dongen JJ, Moll HA, van Zelm MC (2016). Transient reduction in IgA+ and IgG+ memory B cell numbers in young EBV-seropositive children: the Generation R Study. J Leukoc Biol 101: 949-956. PMID: 27821468 DOI: 10.1189/jlb.5VMAB0616-283R
Nicol SM, Sabbah S, Brulois KF, Jung JU, Bell AI, Hislop AD (2016). Primary B lymphocytes infected with KSHV can be expanded in vitro and are recognized by LANA-specific CD4+ T cells. J Virol 90:3849-59. Print 2016 Apr. PMID: 26819313 DOI: 10.1128/JVI.02377-15
Abbott RJ, Pachnio A, Pedroza-Pacheco I, Leese AM, Begum J, Long HM, Croom-Carter D, Stacey A, Moss PAH, Hislop AD, Borrow P, Rickinson AB, Bell AI (2017). Asymptomatic primary infection with Epstein-Barr virus: observations on young adult cases. J Virol 91(21). pii: e00382-17. PMID: 28835490 DOI: 10.1128/JVI.00382-17
Shannon-Lowe C, Rickinson AB and Bell AI (2017). Epstein-Barr virus-associated lymphomas. Phil Trans Roy Soc B. 372:20160271 doi: 10.1098/rstb.2016.0271.
Kelly GL, Fitzsimmons L, Boyce A, Wei W, Change C, Croom-Carter D, Tierney R, Herold M, Bell, A, Strasser A, Rowe M (2018). Coordinated repression of BIM and PUMA by Epstein-Barr virus latent genes maintains the survival of Burkitt lymphoma cells. Cell Death Diff 25:241-254. Epub 2017 Sep 29. PMID: 28960205 DOI: 10.1038/cdd.2017.150
Fitzsimmons L, Cartlidge R, Chang C, Sejic N, Galbraith L, Suraweera C, Croom-Carter D, Dewson G, Tierney R, Bell A, Shannon-Lowe C, Herold M, Rickinson A, Colman M, Huang D, Strasser A, Kvansakul M, Rowe M and Kelly G (2019). EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins Cell Death Differ 27, 1554–1568. https://doi.org/10.1038/s41418-019-0435-1
View all publications in research portal